Neocrin's Series C - III Round

Neocrin raised a round of funding on July 01, 1997.

Researcher and developer of a minimally invasive, encapsulated cellular transplant device for the treatment of diabetes. The company sold its assets to Novocell.…

Articles about Neocrin's Series C - III Round: